Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma

Published:2012-10-11 Issue:5 Volume:18 Page:934-941
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Mahadevan Daruka,Northfelt Donald W.,Chalasani Pavani,Rensvold Diane,Kurtin Sandra,Von Hoff Daniel D.,Borad Mitesh J.,Tibes Raoul

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-012-0475-8.pdf

Reference11 articles.

1. Brana MF, Ramos A (2001) Naphthalimides as anti-cancer agents: synthesis and biological activity. Curr Med Chem Anticancer Agents 1:237–255

2. Ratain MJ, Mick R, Berezin F et al (1993) Phase I study of amonafide dosing based on acetylator phenotype. Cancer Res 53:2304–2308

3. Ratain MJ, Rosner G, Allen SL et al (1995) Population pharmacodynamic study of amonafide: a cancer and leukemia group B study. J Clin Oncol 13:741–747

4. Mijatovic T, Mahieu T, Bruyère C et al (2008) UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia 10(6):573–586

5. Van Quaquebeke E, Mahieu T, Dumont P et al (2007) 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dihydro-1H-benzo[de]isoquinolin-5yl}carbamoyl) acetamide (UNBS3157), a novel non-hematotoxic naphthalimide derivative with potent anti-tumor activity. J Med Chem 50:4122–4134

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered Artesunate-Naphthalimide Hybrid Dual Drug for Synergistic Multimodal Therapy against Experimental Murine Lymphoma;Molecular Pharmaceutics;2024-02-02

2. Tetrahydro-β-carboline-naphthalimide hybrids: Synthesis and anti-proliferative evaluation on estrogen-dependent and triple-negative breast cancer cells;Journal of Molecular Structure;2022-08

3. Synthesis and photobiological applications of naphthalimide–benzothiazole conjugates: cytotoxicity and topoisomerase IIα inhibition;RSC Advances;2022

4. Novel chiral naphthalimide-cycloalkanediamine conjugates: Design, synthesis and antitumor activity;Bioorganic Chemistry;2021-07

5. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer;International Immunopharmacology;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3